1Muasher SJ, Oehninger S, Simonetti S, et al. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome [J]. Fertil Steril, 1988, 50(2): 298-307.
2Abdalla H, Thum MY. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve [J]. Hum Reprod, 2004, 19(4) : 893-898.
3Levi AJ, Raynault MF, Bergh PA, et al. Reproductive outcome in patients with diminished ovarian reserve[J]. Fertil Steril, 2001, 76 (4) : 666-669.
4Jurema MW, Bracero NJ, Garcia JE. Fine tunning cyde day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles [J]. Fertil Steril, 2003, 80(5) : 1156-1161.
5Roberts JE, Spandorfer S, Fasouliotis SJ, et al. Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization [ J]. Fertil Steril, 2005, 83 ( 1 ) : 37-41.
6Abdalla H, Thum MY. Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH [J]. Hum Reprod, 2006,21 ( 1 ) : 171-174.
7Creus M, Penarrubia J, Fábregues F, et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome[ J]. Hum Reprod, 2000, 15 ( 11 ) : 2341-2346.
8Meden-Vrtovec H. Ovarian aging and infertility [J]. Clin Exp Obstet Gynecol, 2004, 31 ( 1 ) : 5-8.
10Espesito MA, Coutifaris C, Barnhart KT. A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women[J]. Hum Reprod, 2002, 17( 1 ) : 118-123.
7Garcia - Velasco J A, Moreno L, Pacheco A, et al. The aromatase inhibitor letrozole increases the concentration of intraovarian andro- gens and improves in vitro fertilization outcome in low responder pa- tients: a pilot study[J]. Fertil Steril,2005,84(1 ):82 -87.
8Schoolcrgt W B, Surrey E S, Minjarez D A, et al. Management of poor responders: can outcomes be improved with a novel gonadotropin -releasing hormone antagonist/letrozole protocol? [ J]. Fertil Ster- i1,2005,89( 1 ) : 151 - 156.
9Garcia - Velasco J A, Moreno L, Pacheeo A, et al. The aromatase inhibitor letrozole increases the concentration of intraovarian andro- gens and improves in vitro fertilization outcome in low responder pa- tients: a pilot study [ J ]. Fertil Steril,2005,84 ( 1 ) : 82 - 87.
10Schoolcraft W B, Surrey E S, Minjarez D A, et al. Management of poor responders: can outcomes be improved with a novel gonadotropin -releasing hormone antagonist/letrozole protocol? [ J ]. Fertil Ster- i1,2008,89( 1 ) : 151 - 156.